Published in Am J Med on February 01, 1994
Medrol Dosepak Taper for Delayed Post-op Recovery After TKA | NCT05113901
Short course prednisolone for adhesive capsulitis (frozen shoulder or stiff painful shoulder): a randomised, double blind, placebo controlled trial. Ann Rheum Dis (2004) 2.54
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis (2005) 2.48
Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology (2011) 2.04
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis (2007) 1.90
Safety of extended treatment with anakinra in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 1.74
Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis (2012) 1.43
Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis. BMJ (1998) 1.33
The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis (1997) 1.33
Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin Ther (2011) 1.29
Glucocorticoids in the treatment of early and late RA. Ann Rheum Dis (2003) 1.20
Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups. Arthritis Res Ther (2006) 1.16
Rheumatology. BMJ (1998) 1.12
Glucocorticoid sensitivity in health and disease. Nat Rev Endocrinol (2013) 1.09
Independent association of glucocorticoids with damage accrual in SLE. Lupus Sci Med (2016) 1.07
Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol (2006) 1.06
Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg (2004) 1.04
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther (2011) 1.04
Corticosteroids in rheumatoid arthritis. BMJ (1998) 1.03
Public health impact of adverse bone effects of oral corticosteroids. Br J Clin Pharmacol (2001) 1.01
Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 0.92
Variable deficits of bone mineral despite chronic glucocorticoid therapy in pediatric patients with inflammatory diseases: a Glaser Pediatric Research Network study. J Pediatr Endocrinol Metab (2006) 0.92
High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass. Osteoporos Int (2005) 0.90
Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada. Cost Eff Resour Alloc (2010) 0.88
The value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effects. Arthritis Res Ther (2014) 0.87
Krüppel-Like Factor 15 Mediates Glucocorticoid-Induced Restoration of Podocyte Differentiation Markers. J Am Soc Nephrol (2016) 0.86
Rates of serious intracellular infections in autoimmune disease patients receiving initial glucocorticoid therapy. PLoS One (2013) 0.85
A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China. Rheumatol Int (2008) 0.84
[Insufficiency fractures in rheumatology. Case report and overview]. Z Rheumatol (2006) 0.83
Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study. BMC Pulm Med (2011) 0.81
Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy. Support Care Cancer (2013) 0.80
Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab. J Nephrol (2014) 0.80
Spontaneous multiple insufficiency fractures after pelvic abscess and sepsis in a rheumatoid arthritis patient treated with high-load corticosteroid therapy: a case report. Clin Rheumatol (2007) 0.80
Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial. Ann Rheum Dis (2008) 0.79
[Insufficiency fractures of the feet and lower limbs in rheumatoid arthritis]. Z Rheumatol (2011) 0.78
A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs. Ann Rheum Dis (2005) 0.78
Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures. Clin Rheumatol (2006) 0.78
Half of UK patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study. Arthritis Res Ther (2015) 0.78
Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancer. Eur J Clin Microbiol Infect Dis (2014) 0.78
Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone. BMC Gastroenterol (2013) 0.78
Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study. BMC Musculoskelet Disord (2016) 0.78
[Prescription of glucocorticoids by rheumatologists in patients with rheumatoid arthritis in Germany]. Z Rheumatol (2005) 0.77
Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing. Ann Rheum Dis (1997) 0.77
Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy. Nat Rev Urol (2015) 0.77
Steroids cause osteoporosis. Ann Rheum Dis (2002) 0.77
Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in olmsted county, Minnesota. Gastroenterol Res Pract (2011) 0.77
Time trends in glucocorticoid use in rheumatoid arthritis: results from a population-based inception cohort, 1980-1994 versus 1995-2007. Arthritis Care Res (Hoboken) (2014) 0.77
Serious infections under treatment with TNF-alpha antagonists compared to traditional DMARDs in patients with rheumatoid arthritis. Rheumatol Int (2006) 0.76
Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease. Osteoporos Int (2012) 0.76
The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin. Rheumatol Int (2005) 0.76
Serious adverse events with low-dose, long-term corticosteroid therapy in rheumatoid arthritis. Am J Med (1995) 0.76
Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats. Clin Interv Aging (2015) 0.76
Inhibition of Klebsiella pneumoniae growth by selected Australian plants: natural approaches for the prevention and management of ankylosing spondylitis. Inflammopharmacology (2017) 0.76
Prednisone Use and Risk of Mortality in Patients With Rheumatoid Arthritis: Moderation by Use of Disease-Modifying Antirheumatic Drugs. Arthritis Care Res (Hoboken) (2016) 0.75
Early corticosteroid withdrawal regimen in a living donor kidney transplantation program. Indian J Nephrol (2014) 0.75
Is there a place for nonbiological drugs in the treatment of rheumatoid arthritis? Ther Adv Musculoskelet Dis (2010) 0.75
Health-related quality of life in children with chronic immune thrombocytopenia in China. Health Qual Life Outcomes (2016) 0.75
Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. Clin Lymphoma Myeloma Leuk (2012) 0.75
[Factors associated with infection in rheumatoid arthritis]. Pan Afr Med J (2013) 0.75
The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.75
Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis. Can J Gastroenterol Hepatol (2016) 0.75
Corticosteroid prescribing in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol (1998) 0.75
Effects of long-term corticosteroid usage on functional disability in patients with early rheumatoid arthritis, regardless of controlled disease activity. Rheumatol Int (2010) 0.75
Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New? Dig Dis Sci (2016) 0.75
Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance. Drug Saf (2017) 0.75
[Cortisone therapy today]. Wien Klin Wochenschr (2003) 0.75
The effect of low-dose prednisone on bone mineral density in Peruvian rheumatoid arthritis patients. Rheumatol Int (2003) 0.75
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med (2000) 16.20
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med (1999) 6.84
Accuracy of data in abstracts of published research articles. JAMA (1999) 6.42
Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn Health (1997) 4.63
Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet (1998) 4.44
Knowledge of the Tuskegee study and its impact on the willingness to participate in medical research studies. J Natl Med Assoc (2000) 3.82
Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol (1997) 3.31
Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum (1994) 3.15
Pesticides and other agricultural risk factors for non-Hodgkin's lymphoma among men in Iowa and Minnesota. Cancer Res (1992) 2.92
Factors that influence African-Americans' willingness to participate in medical research studies. Cancer (2001) 2.86
Ocular manifestations of giant cell arteritis. Am J Ophthalmol (1998) 2.84
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis (2009) 2.76
Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis. J Endocrinol Invest (1990) 2.70
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis. Arthritis Rheum (2010) 2.37
A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum (2001) 2.37
Microchimerism of maternal origin persists into adult life. J Clin Invest (1999) 2.35
The dropout problem in antihypertensive treatment. A pilot study of social and emotional factors influencing a patient's ability to follow antihypertensive treatment. J Chronic Dis (1970) 2.30
Terminal care for children dying of cancer: quantity and quality of life. Br Med J (Clin Res Ed) (1985) 2.19
Proportionate mortality study of golf course superintendents. Am J Ind Med (1996) 2.15
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum (2001) 2.11
Pesticide exposures and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Res (1990) 2.03
Improving care for minority children with asthma: professional education in public health clinics. Pediatrics (1997) 2.02
A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage. JAMA (1995) 2.02
Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1994) 2.01
Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology (1987) 2.00
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study. Ann Rheum Dis (2005) 1.84
Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum (1978) 1.83
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum (2000) 1.82
Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. Ann Intern Med (1981) 1.79
Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience. Rheumatology (Oxford) (2004) 1.76
Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration. Ann Rheum Dis (1984) 1.76
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum (1999) 1.75
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis (2010) 1.73
Integrative assessment of multiple pesticides as risk factors for non-Hodgkin's lymphoma among men. Occup Environ Med (2003) 1.70
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis (2006) 1.70
Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis. Arthritis Rheum (2001) 1.65
Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (Anismus). Neurogastroenterol Motil (2004) 1.65
The role of endotoxin in grain dust-induced lung disease. Am J Respir Crit Care Med (1995) 1.64
Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood (1999) 1.63
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2000) 1.62
Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis. J Rheumatol (1996) 1.57
Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol (1998) 1.57
Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol (1992) 1.56
Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Leuk Res (1991) 1.54
A waterborne outbreak of gastroenteritis in adults associated with Escherichia coli. Lancet (1968) 1.53
Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum (1990) 1.53
Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol (2001) 1.52
One hundred deaths in practice. A study of terminal care. J R Coll Gen Pract (1971) 1.52
Developing and communicating a long-term treatment plan for asthma. Am Fam Physician (2000) 1.49
Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr (1996) 1.49
Determinants of longitudinal changes in spirometric function among swine confinement operators and farmers. Am J Respir Crit Care Med (1995) 1.48
The clinical utility and reliability of asbestos bodies in bronchoalveolar fluid. Am Rev Respir Dis (1991) 1.47
Infliximab in active early rheumatoid arthritis. Ann Rheum Dis (2004) 1.47
Measurement of red cell survival using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion (1999) 1.46
Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam, and piroxicam alone. Arthritis Rheum (1995) 1.44
Ischemic heart disease mortality in Iowa farmers. The influence of life-style. JAMA (1982) 1.44
Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum (1990) 1.43
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum (2001) 1.42
Modeling mortality risk in hemodialysis patients using laboratory values as time-dependent covariates. Am J Kidney Dis (1996) 1.40
Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis. J Rheumatol Suppl (1985) 1.40
The emperor's new clothes. Nondisease and workplace disability. J Fla Med Assoc (1991) 1.39
A taxpayer's view of the elderly's lament on the Medicare Catastrophic Coverage Act. J Fla Med Assoc (1989) 1.39
Remolding the contours of national health insurance. J Fla Med Assoc (1992) 1.39
Patients' rights vs animal rights. J Fla Med Assoc (1992) 1.38
Regulatory intrusion into patient pain relief. J Fla Med Assoc (1995) 1.38
How useful is ultrasound in the management of abdominal malignancy? Arch Dis Child (1984) 1.38
Fraud and abuse revisited. Current schemes and scams in Florida. J Fla Med Assoc (1994) 1.38
HIV and Mr. Helms. J Fla Med Assoc (1991) 1.38
Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma. Cancer Causes Control (1992) 1.35
Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992. Eur J Cancer (2000) 1.32
Low 'gynecologic': an obstetric risk factor. Am J Obstet Gynecol (1977) 1.31
Indoor environmental quality in six commercial office buildings in the midwest United States. Appl Occup Environ Hyg (2001) 1.30
Evaluation of risks for non-Hodgkin's lymphoma by occupation and industry exposures from a case-control study. Am J Ind Med (1993) 1.29
Adverse reactions to antimicrobial agents. JAMA (1974) 1.29
Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions. J Immunol (1976) 1.29
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. Ann Rheum Dis (2004) 1.28
Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1994) 1.27
Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Ann Rheum Dis (2007) 1.26
Airway injury in swine confinement workers. Ann Intern Med (1992) 1.26
Longitudinal evaluation of dose-response relationships for environmental exposures and pulmonary function in swine production workers. Am J Ind Med (1996) 1.26
The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year. Ann Rheum Dis (2006) 1.24
A comparison of national infection and immunization estimates for measles and rubella. Am J Public Health (1978) 1.24
Quantitative determinations of complement components and immunoglobulins in tears and aqueous humor. Invest Ophthalmol (1974) 1.23
Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol (1989) 1.23
Cancer mortality among Iowa farmers: recent results, time trends, and lifestyle factors (United States). Cancer Causes Control (1998) 1.22
Measurement of circulating red cell volume using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion (1999) 1.21
Weber-Christian disease. Analysis of 15 cases and review of the literature. Medicine (Baltimore) (1985) 1.20
Glucocorticoids in the treatment of early and late RA. Ann Rheum Dis (2003) 1.20
Stress and symptoms in patients with interstitial cystitis: a life stress model. Urology (2001) 1.19
Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res (2001) 1.19
Is running associated with degenerative joint disease? JAMA (1986) 1.18
Activation of the classical and alternate pathways of complement by Corynebacterium parvum. Clin Exp Immunol (1975) 1.18
The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis. Ann Intern Med (1981) 1.18
Cancer mortality in Iowa farmers, 1971-78. J Natl Cancer Inst (1981) 1.17
Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol (1997) 1.17
Circulating red cell volume and red cell survival can be accurately determined in sheep using the [14C]cyanate label. Pediatr Res (1997) 1.16
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum (1999) 1.16